Maxor is not just a vendor, we’re your partner. We have over a decade of experience with the 340B program and a track record to prove it. Together we can help your organization extend your patient reach and care. Continue reading to see how we have helped other entities.
In 2002, Maxor was instrumental in helping a DSH achieve 340B pricing. Under Maxor’s management since that time, the DSH has saved tens of millions of dollars in medication expense. In 2012, This DSH successfully emerged from a HRSA 340B audit with no findings whatsoever. Maxor’s participation in this audit was a critical component of this success.
In 2010, Maxor opened an FQHC Pharmacy in New York, filling HIV medications for clinic patients and utilizing a replenishment model to serve both qualified 340B patients and non-qualified patients. Maxor maintains a 340B compliant split billing inventory system, as well as conducts periodic self-audits on behalf of this client. In April 2014, this FQHC was audited by HRSA 340B and there were no adverse findings on the retail pharmacy Maxor manages.
In 2012, a DSH retained Maxor to institute a 340B pharmacy program to serve qualified discharge patients, as well as qualified employees of the hospital system. In August of 2013, this DSH successfully emerged from a HRSA 340B audit with no findings regarding the retail pharmacy Maxor manages.